Objective Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by
one or more of the following features: intraluminal thrombus organization, fibrous stenosis …

Background Chronic thromboembolic pulmonary hypertension (CTEPH) is generally
recognized to be caused by persistent organized thrombi that occlude the pulmonary …

OBJECTIVE: Pulmonary arterial hypertension (PAH) is a rare condition, with an incidence of
15-50 cases per million annually. Available studies demonstrate that despite the longer …

BACKGROUND: The exercise capacity of patients with thromboembolic pulmonary
hypertension was investigated to clarify the long-term effects of pulmonary endarterectomy …

Objective Few studies have reported predictive factors of outcome after pulmonary
endarterectomy (PEA) in chronic thromboembolic pulmonary hypertension. The purpose of …

Background and Objectives: Chronic thromboembolic pulmonary hypertension (CTEPH) has
a high mortality. The treatment of CTEPH could be balloon pulmonary angioplasty (BPA) …

Abstract Background Chronic Thromboembolic Pulmonary Hypertension (CTEPH) results
from incomplete resolution of a pulmonary embolus, leading to pulmonary hypertension and …

This study aimed to evaluate the feasibility of a noninvasive operability assessment of
chronic thromboembolic pulmonary hypertension (CTEPH) based on multidetector …

Pulmonary thromboendarterectomy (PTE) surgery is an effective treatment for the majority of
patients with chronic thromboembolic pulmonary hypertension (CTEPH), with an acceptable …

Background Balloon pulmonary angioplasty (BPA) has beneficial effects on pulmonary
hemodynamics, exercise capacity, and quality of life (QOL) in patients with chronic …